Neuronal intranuclear inclusion disease tremor-dominant subtype: a mimicker of essential tremor
Objective: This study aimed to clarify the clinical phenotype in tremor-dominant patients having the GGC repeat expansion in the NOTCH2NLC gene. Background: The GGC repeat…Comparison of pre – and post – clinical outcomes after COVID-19 lockdown in people with Parkinson’s in Portugal
Objective: We compare several pre- and post-clinical outcomes to assess the effects in a group of Portuguese people with PD. Background: Government-mandated restrictions due to…Prevalence and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in a Large Canadian Cohort from Ontario
Objective: To describe the prevalence and clinical characteristics of Autosomal Dominant (AD) Spinocerebellar Ataxias (SCA) in a Canadian cohort of patients in Ontario. Background: SCAs…Clinical phenotype and biomarkers in sporadic degenerative ataxia: longitudinal data from the SPORTAX registry
Objective: Our aim was to survey the natural history of sporadic degenerative ataxia and analyze the long-term disease progression. Furthermore, we wanted to examine and…Choreoathetosis in the setting of HHV-6 infection in an allogeneic transplant recipient
Objective: To illustrate a novel case of adult-onset choreoathetosis in the setting of HHV-6 infection Background: Human herpesvirus-6 (HHV-6) has been associated with a spectrum…Homeostatic Improvement of Brain Bioenergetic Metabolism in Parkinson’s Disease: Results From A Phase 2 REPAIR-PD Clinical Trial With CNM-Au8
Objective: To determine the effects of the nanocatalytic drug, CNM-Au8, on brain energy metabolites in Parkinson’s Disease. Background: Converging lines of evidence are identifying brain…Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE
Objective: This analysis evaluated the sustained effects of onabotulinumtoxinA in patients with CD who were naive or non-naive to botulinum toxin at enrollment in CD…Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies
Objective: The aim of this meta-analysis of pivotal studies was to evaluate the efficacy of abobotulinumtoxinA (AboBoNT-A) in reducing pain in patients with cervical dystonia…A case of YY1-related isolated dystonia with severe oromandibular involvement
Objective: 0 Background: Introduction: YY1 disease-causing variants are responsible for Grabiele-de-Vries syndrome, an autosomal dominant condition characterized by psychomotor developmental (PD) delay, cognitive impairment, facial dysmorphism…Exploring Local Field Potential changes in Dystonic Camptocormia.
Objective: To describe a novel technology for detection of local field potentials in bilateral GPi-DBS to identify local field potential biomarker changes in dystonic camptocormia.…
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 132
- Next Page »